CBC News-Biotech firm recruiting Yukon men for trial, Prostate cancer group says it could save lives

2022-01-04T19:09:39+00:00

Alberta-based Nanostics is hoping to recruit 200 Yukoners to the clinical validation study testing ClarityDX Prostate in a real-world setting.

Full Article
CBC News-Biotech firm recruiting Yukon men for trial, Prostate cancer group says it could save lives2022-01-04T19:09:39+00:00

CKRW 96.1 FM Radio-Cancer Study Comes to the Yukon

2022-01-04T19:10:13+00:00

The Yukon Ride for Dad, which raises money for prostate cancer awareness and research, is making a substantial investment in Nanostic’s research into diagnostic testing for prostate cancer.

Full Article
CKRW 96.1 FM Radio-Cancer Study Comes to the Yukon2022-01-04T19:10:13+00:00

Movember and Alberta Cancer Foundation campaigns boost prostate cancer screening study

2022-01-04T19:11:01+00:00

News Medical Lifesciences – ClarityDX Prostate cancer diagnostic test validation study gets a boost in recruitment thanks to concurrent fundraising campaigns.

Full Article
Movember and Alberta Cancer Foundation campaigns boost prostate cancer screening study2022-01-04T19:11:01+00:00

ClarityDX Prostate clinical validation study is expanding into the US with Century Clinical Research, Inc.

2022-01-04T19:11:32+00:00

The Nanostics & APCaRI co-sponsored ClarityDX Prostate clinical validation study is expanding into the US by opening the Daytona Beach, Florida Century Clinical Research, Inc. recruitment site.

Full Article
ClarityDX Prostate clinical validation study is expanding into the US with Century Clinical Research, Inc.2022-01-04T19:11:32+00:00

Nanostics featured on Alberta Impact Episode 5 with Bryce Lambert

2022-01-04T19:12:04+00:00

1 of 7 Canadian men is diagnosed with prostate cancer each year. We cannot emphasize enough on how important it is to get tested each year. Nanostics has come up with a non-invasive diagnostic test to bring clarity to healthcare decisions. Their core technology is in development to be able to diagnose prostate cancer from a simple blood test.

Full Article
Nanostics featured on Alberta Impact Episode 5 with Bryce Lambert2022-01-04T19:12:04+00:00

The Cancer Consortium-Nanostics: Advanced Machine Learning to Detect Prostate Cancer

2022-01-04T19:12:39+00:00

Nanostics’ core technology, ClarityDX, combines a sensitive extracellular vesicle detection platform with advanced machine learning to diagnose a disease from a simple blood test.

Full Article
The Cancer Consortium-Nanostics: Advanced Machine Learning to Detect Prostate Cancer2022-01-04T19:12:39+00:00

Prostate Cancer News Today: Nanostics Launches Pivotal Study to Validate ClarityDX Prostate Diagnostic Test.

2022-01-04T19:13:18+00:00

Ana Pena wrote for the Prostate Cancer News Today: The company says the diagnostic tool has the potential to spare many men unnecessary biopsies and treatments.

Full Article
Prostate Cancer News Today: Nanostics Launches Pivotal Study to Validate ClarityDX Prostate Diagnostic Test.2022-01-04T19:13:18+00:00

Faculty of Medicine & Dentistry: U of A spin-off company Nanostics launches clinical validation study for ClarityDX Prostate

2022-01-04T19:13:46+00:00

NEWS STAFF REPORT: Blood test predicts aggressive prostate cancer with greater accuracy and less patient discomfort.

Full Article
Faculty of Medicine & Dentistry: U of A spin-off company Nanostics launches clinical validation study for ClarityDX Prostate2022-01-04T19:13:46+00:00

Nanostics and DynaLIFE productive partnership – video interview with Edmonton Journal

2022-01-04T19:14:37+00:00

CSO Desmond Pink discusses Nanostics’ productive partnership with DynaLIFE Medical labs’ Translational Research Program- a key relationship to bring ClarityDX to market.

Full Article
Nanostics and DynaLIFE productive partnership – video interview with Edmonton Journal2022-01-04T19:14:37+00:00

Nanostics develops better tests En Route magazine

2022-02-08T23:37:35+00:00

Illustration by Martina Paukova

Full Article
Nanostics develops better tests En Route magazine2022-02-08T23:37:35+00:00
Go to Top